Rutenberg Cancer Center /ID# 244647 — New York, New York

Rutenberg Cancer Center /ID# 244647 is a clinical research site located in New York, New York, United States 10029-6030.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Rutenberg Cancer Center /ID# 244647 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Relapsed/Refractory Multiple Myeloma.

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rutenberg Cancer Center /ID# 244647?

Rutenberg Cancer Center /ID# 244647 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rutenberg Cancer Center /ID# 244647 conducted?

Rutenberg Cancer Center /ID# 244647 has 1 clinical trials on record, with 1 currently active. Their work covers Relapsed/Refractory Multiple Myeloma.

Is Rutenberg Cancer Center /ID# 244647 accredited by Crixeo Health?

Rutenberg Cancer Center /ID# 244647 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rutenberg Cancer Center /ID# 244647?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.